a Clinical Research of Sequential CAR-T Bridging HSCT in the Treatment of Relapse/Refractory B-cell Malignancies

Clinical trial NCT02846584 · UNKNOWN

Trial details

NCT number: NCT02846584
Sponsor: Southwest Hospital, China
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, Large B-Cell, Diffuse Leukemia, Lymphocytic, Chronic, B-Cell Lymphoma，Malignant

Start date: 2016-07-01
Primary completion: 2019-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.